Mallinckrodt Hit With Investor Suit After Mulling 2nd Ch. 11
Drugmaker Mallinckrodt PLC deceived shareholders that it had bounced back from bankruptcy and would be able to pay $200 million to an opioid fund, according to a proposed class action filed...To view the full article, register now.
Already a subscriber? Click here to view full article